Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
Med. 2024 Apr 12;5(4):311-320.e3. doi: 10.1016/j.medj.2024.02.003. Epub 2024 Mar 11.
Med. 2024.
PMID: 38471508
Clinical Trial.
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Amaria R, Knisely A, Vining D, Kopetz S, Overman MJ, Javle M, Antonoff MB, Tzeng CD, Wolff RA, Pant S, Lito K, Rangel K, Fellman B, Yuan Y, Lu KH, Sakellariou-Thompson D, Haymaker CL, Forget MA, Hwu P, Bernatchez C, Jazaeri AA.
Amaria R, et al. Among authors: lito k.
J Immunother Cancer. 2024 Feb 2;12(2):e006822. doi: 10.1136/jitc-2023-006822.
J Immunother Cancer. 2024.
PMID: 38309721
Free PMC article.
Item in Clipboard
Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer.
Knisely A, Hinchcliff EM, Gardiner E, Rangwala R, Lito K, Fellman B, Yuan Y, Sood AK, Westin SN, Lu KH, Jazaeri AA.
Knisely A, et al. Among authors: lito k.
iScience. 2024 Apr 23;27(5):109801. doi: 10.1016/j.isci.2024.109801. eCollection 2024 May 17.
iScience. 2024.
PMID: 38726365
Free PMC article.
Item in Clipboard
Cite
Cite